page_banner

Products

Flucytosine CAS: 2022-85-7

Short Description:

Catalog Number: XD93436
Cas: 2022-85-7
Molecular Formula: C4H4FN3O
Molecular Weight: 129.09
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD93436
Product Name Flucytosine
CAS 2022-85-7
Molecular Formula C4H4FN3O
Molecular Weight 129.09
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Flucytosine, also known as 5-fluorocytosine or 5-FC, is a synthetic antifungal medication that is primarily used for the treatment of fungal infections. It is classified as an antimetabolite, which means it interferes with the normal metabolic processes of fungal cells, leading to their inhibition or death. Flucytosine is usually administered in combination with other antifungal agents for optimal efficacy.One of the key uses of flucytosine is in the treatment of invasive fungal infections, particularly those caused by the species Candida and Cryptococcus. It is often used in combination with another antifungal agent, such as amphotericin B or fluconazole, to enhance its antifungal activity. Flucytosine works by entering fungal cells and undergoing conversion into 5-fluorouracil, a cytotoxic antimetabolite. 5-fluorouracil then interferes with the synthesis of fungal RNA and DNA, thereby inhibiting fungal growth and replication. This synergistic approach helps to combat a broader spectrum of fungal pathogens and increase treatment effectiveness.Another important use of flucytosine is in the treatment of Cryptococcus neoformans meningitis, a potentially life-threatening infection that affects the membranes surrounding the brain and spinal cord. Flucytosine is considered one of the first-line therapies in combination with amphotericin B for the treatment of this condition. The combination therapy helps to overcome the limitations of each drug alone and achieve higher cure rates. Flucytosine reaches adequate levels in the cerebrospinal fluid, allowing it to effectively target the fungal infection in the central nervous system.Flucytosine may also be used for the treatment of other fungal infections, such as infections caused by certain species of Candida and Aspergillus. However, its use may be limited due to the risk of developing resistance, as the fungus can acquire mutations that make it less susceptible to the drug. Close monitoring and periodic evaluation of therapeutic response are essential when using flucytosine to ensure appropriate treatment outcomes.Although flucytosine is generally well-tolerated, it can have some adverse effects. Common side effects include gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. It can also cause bone marrow suppression, which may result in decreased production of blood cells. Regular blood tests are often performed to monitor blood cell counts during treatment.In summary, flucytosine is an antifungal medication that is used in combination therapy for the treatment of fungal infections, particularly those caused by Candida and Cryptococcus species. It acts by interfering with fungal nucleic acid synthesis, inhibiting their growth and replication. Flucytosine is commonly used in combination with other antifungal agents and is especially crucial in the treatment of Cryptococcus neoformans meningitis. However, its use requires careful monitoring due to the risk of resistance and potential adverse effects.


  • Previous:
  • Next:

  • Close

    Flucytosine CAS: 2022-85-7